未登录

X

Xue Y. Zhu

State University System of Florida

H指数:16

被引数:760

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2024-05-014

OA

In vitro evaluation of novel pyrimidine nucleosides for the treatment of pancreatic cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Development and evaluation of novel gemcitabine analog for the treatment of pancreatic cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Synthesis and biological evaluation of novel 5-FU analogs against pancreatic cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Direction-Aware and Foreground-Guided Remote Sensing Road Detection

方向感知和前景引导的遥感道路检测

ieee geoscience and remote sensing magazine

IF4.4

2024-01-010

PRE

Local-Global Feature Capture and Boundary Information Refinement Swin Transformer Segmentor for Remote Sensing Images

IF3.6

2024-01-019

OA

Confidence-Based Weakly Supervised for Aircraft Detection From Remote Sensing Image

ieee geoscience and remote sensing magazine

IF4.4

2024-01-010

PRE

Contactless evaluation of rigidity in Parkinson's disease by machine vision and machine learning

CHINESE MEDICAL JOURNAL

IF7.3

2023-06-211

OAAI

Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

IF3.4

2023-05-135

OAAI

Characterization and evaluation of modified 5-fluorouracil loaded liposomal nanoparticle on pancreatic and colorectal cancer cell lines

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

IF3.4

2022-12-223

OAAI

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models

吉西他滨在胰腺患者来源的异种移植小鼠模型中的增强功效

international journal of pharmaceutics

IF6.4

2020-12-0113

OAAI

New analogs of SYA013 as sigma-2 ligands with anticancer activity

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-06-0113

OAAI

SYA 013 analogs as moderately selective sigma-2 (σ2) ligands: Structure-affinity relationship studies

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-06-016

OAAI

Synthesis and evaluation of the structural elements in alkylated tetrahydroisoquinolines for binding to CNS receptors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-11-0111

OAAI

Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-08-014

OAAI

Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands

双5-HT1A和5-HT7受体配体的设计与合成

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-08-0120

OAAI

Energy Efficiency Maximization by Jointly Optimizing the Positions and Serving Range of Relay Stations in Cellular Networks

IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY

IF7.1

2015-06-0136

PREAI

Identification of a new selective dopamine D4 receptor ligand

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2014-06-0133

OAAI

Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2013-12-018

OAAI